Status:
COMPLETED
Muscle Weakness Duration After Single Botulinum Toxin Injection in Masseter
Lead Sponsor:
Region Västerbotten
Collaborating Sponsors:
Umeå University
Mahidol University
Conditions:
Bite Force
Botulinum Toxins, Type A
Eligibility:
FEMALE
18-120 years
Phase:
NA
Brief Summary
This study aimed to evaluate the duration of a reduced maximal voluntary bite force after a botulinum toxin intervention. Methods: In an intervention group, 25 units of Xeomin® (Merz Pharma GmbH \& Co...
Detailed Description
This study aimed to evaluate the duration of a reduced maximal voluntary bite force (MVBF) after a botulinum toxin intervention. Methods: In an intervention group, 25 units of Xeomin® (Merz Pharma Gmb...
Eligibility Criteria
Inclusion
- Healthy subjects seeking aesthetical treatment to reduce masseter muscle volume.
Exclusion
- Conditions or drugs affecting the central nervous system.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 14 2022
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT05309564
Start Date
March 1 2020
End Date
March 14 2022
Last Update
May 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Norrlands universitetssjukhus
Umeå, Västerbotten County, Sweden, 90185